Review



anti human foxp3  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc anti human foxp3
    Anti Human Foxp3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Rabbit+mAb/pmc13006417-27-0-4
    Average 96 stars, based on 164 article reviews
    anti human foxp3 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Immunohistochemistry:

    Article Title: Targeting the STAT5A/IDO1 Axis Overcomes Radiotherapy Resistance and Reverses Immunosuppressive Tumor Microenvironment in Non-Small Cell Lung Cancer
    Article Snippet: Background: Radiotherapy (RT) combined with immunotherapy is an important point of contention in non-small cell lung cancer (NSCLC) research.. As an important metabolic mediator of antitumor immunity, indoleamine-2,3-dioxygenase 1 (IDO1) is reportedly upregulated in a variety of cancers.. However, the regulatory mechanism and clinical Manuscript Click here to view linked References This preprint research paper has not been peer reviewed.

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 . .. The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), anti-PD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm-30107M, Bioss antibodies, Beijing, China), rabbit anti-RGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PD-L2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade.
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO2. .. Antibodies and reagents The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), antiPD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm30107M, Bioss antibodies, Beijing, China), rabbit antiRGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PDL2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/ Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/ Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Western Blot:

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 . .. The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), anti-PD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm-30107M, Bioss antibodies, Beijing, China), rabbit anti-RGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PD-L2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade.
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO2. .. Antibodies and reagents The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), antiPD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm30107M, Bioss antibodies, Beijing, China), rabbit antiRGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PDL2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/ Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/ Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Immunofluorescence:

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 . .. The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), anti-PD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm-30107M, Bioss antibodies, Beijing, China), rabbit anti-RGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PD-L2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade.
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO2. .. Antibodies and reagents The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), antiPD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm30107M, Bioss antibodies, Beijing, China), rabbit antiRGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PDL2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/ Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/ Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Chromatin Immunoprecipitation:

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 . .. The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), anti-PD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm-30107M, Bioss antibodies, Beijing, China), rabbit anti-RGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PD-L2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade.
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO2. .. Antibodies and reagents The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), antiPD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm30107M, Bioss antibodies, Beijing, China), rabbit antiRGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PDL2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/ Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/ Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Flow Cytometry:

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 . .. The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), anti-PD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm-30107M, Bioss antibodies, Beijing, China), rabbit anti-RGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PD-L2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    Article Title: PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade.
    Article Snippet: These cells were cultured in Dulbecco Modified Eagle Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO2. .. Antibodies and reagents The antibodies used in this study were as follows: rabbit anti-human PD-L2 (#82723, Cell Signaling Technology, Beverly, MA, USA; 1:100 for immunohistochemistry (IHC)), rabbit anti-human PD-L1 (#13684, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), rabbit anti-human FOXP3 (#98377, Cell Signaling Technology, Beverly, MA, USA; 1:100 for IHC), anti-p-p65 (#3033, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot), antiPD-L2 (#ab87662, Abcam, Cambridge, MA, USA; 1:1000 for western blot), mouse anti-PD-L2 (#bsm30107M, Bioss antibodies, Beijing, China), rabbit antiRGMB (#bs-11474R, Bioss antibodies, Beijing, China; 1:1000 for western blot), anti-RGMB (#A12859, Abclonal, China; 1:1000 for western blot), anti-PDL2 (#ab288298, Abcam, Cambridge, MA, USA; 1:50 for Co-immunoprecipitation); anti-β-Actin (#A1978, Sigma, St. Louis, MO, USA; 1:5000 for western blot), anti-PD-L2 (#sc-57398, Santa cruz, USA; 1:50 for IHC), anti-PD-L2 (#NBP1-76770, Novus iologicals, LLC, USA; 1:100 for immunofluorescence assay), anti-p65 (#A19653, Abclonal, China; 1:1000 for western blot), anti-AhR (#83200, Cell Signaling Technology, Beverly, MA, USA; 1:1000 for western blot, 1:50 for Chromatin immunoprecipitation (CHIP)), Zombie AquaTM dye (#423101,Biolegend; 1:1000 for flow cytometry), BUV395 anti-mouse CD45 (#745698, BD OptiBuild, 1:100 for flow cytometry), APC anti-mouse CD4 (#100411,Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD8a (#100721,Biolegend; 1:20 for flow cytometry), APC/Cy7 anti-mouse CD11b (#101225, Biolegend; 1:20 for flow cytometry), PE/ Cy5 anti-mouse F4/80 (#123111, Biolegend; 1:20 for flow cytometry), PE anti-mouse Gr1 (#108407, Biolegend; 1:20 for flow cytometry), APC anti-mouse CD206 (#141707, Biolegend; 1:20 for flow cytometry), PE/ Cy7 anti-mouse MHCII (#107629, Biolegend; 1:20 for flow cytometry), PE/Cy7 anti-mouse CD86 (#105013, Biolegend; 1:20 for flow cytometry), PE anti-mouse FOXP3 (#12-4776-41, eBioscience; 1:20 for flow cytometry), PE anti-human PD-L1 (#329705, Biolegend; 1:20 for flow cytometry), and PE anti-human PD-L2 (#329605, Biolegend; 1:20 for flow cytometry). .. Benzo(a)pyrene (#B1760), Alpha-Naphthoflavone (ANF; #N5757), Puromycin, and RNase A were purchased from Sigma-Aldrich.

    other:

    Article Title: Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
    Article Snippet: Rabbit anti-human FoxP3 (Cell signalling technology,Hitchin, UK).



    Similar Products

    94
    Bioss rabbit anti human polyclonal antibody
    Rabbit Anti Human Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Polyclonal+Antibody/pm41176887-106-41-49
    Average 94 stars, based on 1 article reviews
    rabbit anti human polyclonal antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti human foxp3
    Anti Human Foxp3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Rabbit+mAb/pmc13006417-27-0-4
    Average 96 stars, based on 1 article reviews
    anti human foxp3 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    86
    Servicebio Inc rabbit anti human foxp3
    Rabbit Anti Human Foxp3, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/anti+foxp3/pm41605945-192-38-41
    Average 86 stars, based on 1 article reviews
    rabbit anti human foxp3 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit monoclonal anti human foxp3
    (A) Representative flow cytometry plot and gating strategy for determining ST2 + cell identity in day 2 oral wounds. (B) EPCAM + (epithelial), PDGFRA + (fibroblast), CD31 + (endothelial), and CD45 + (leukocyte) cells that express ST2, normalized by total ST2 + cell count per time point. (C) scRNA-seq analysis and UMAP plot of CD45 + sorted cells from day 2 wounds of control Il33 f/f mice (Ctrl) and experimental ΔIL33 Col1α2 mice. 8–10 wounds from 4–5 mice were pooled per condition. (D) Left: UMAP of subset clusters that express Il1rl1 + (encoding ST2). Right: feature plot of Il1rl1 expression in three clusters. (E) Dot plot for genes that are enriched in Treg cells, including <t>Foxp3</t> . (F) Il1rl1 + cell numbers in each cluster normalized by total number of Il1rl1 + cells. Treg, regulatory T cell; MC, mast cell; ILC2, type 2 innate lymphoid cell. (G) Pseudobulk analysis of DEGs, comparing Treg cells from control versus ΔIL33 Col1α2 groups. (H) GO analysis for the upregulated gene list in control Treg cells. Biological process terms associated with immune responses are shown. (I) CellChat analysis of ligand-receptor interaction pairs. Treg cells are set as the ligand source and other leukocytes as the recipients. Communication probability from the control and ΔIL33 Col1α2 (conditional knockout [cKO]) groups are shown. (J) Violin plots of Mif and Tgfb1 expression in Treg cell cluster from control and ΔIL33 Col1α2 groups. (K) Flow cytometry plots of MIF and TGF-β1 expression in FOXP3 + Treg cells from day 2 wounds of control or ΔIL33 Col1α2 mice. (L) Mean fluorescent intensity (MFI) for MIF or TGF-β1 expression in FOXP3 + Treg cells in day 2 wounds. Data represent mean ± SEM; n = 3–5 mice per group. Student’s t test, * p < 0.05.
    Rabbit Monoclonal Anti Human Foxp3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Rabbit+mAb/pmc12955373-25-0-7
    Average 96 stars, based on 1 article reviews
    rabbit monoclonal anti human foxp3 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    86
    Servicebio Inc foxp3 rabbit anti human antibody
    (A) Representative flow cytometry plot and gating strategy for determining ST2 + cell identity in day 2 oral wounds. (B) EPCAM + (epithelial), PDGFRA + (fibroblast), CD31 + (endothelial), and CD45 + (leukocyte) cells that express ST2, normalized by total ST2 + cell count per time point. (C) scRNA-seq analysis and UMAP plot of CD45 + sorted cells from day 2 wounds of control Il33 f/f mice (Ctrl) and experimental ΔIL33 Col1α2 mice. 8–10 wounds from 4–5 mice were pooled per condition. (D) Left: UMAP of subset clusters that express Il1rl1 + (encoding ST2). Right: feature plot of Il1rl1 expression in three clusters. (E) Dot plot for genes that are enriched in Treg cells, including <t>Foxp3</t> . (F) Il1rl1 + cell numbers in each cluster normalized by total number of Il1rl1 + cells. Treg, regulatory T cell; MC, mast cell; ILC2, type 2 innate lymphoid cell. (G) Pseudobulk analysis of DEGs, comparing Treg cells from control versus ΔIL33 Col1α2 groups. (H) GO analysis for the upregulated gene list in control Treg cells. Biological process terms associated with immune responses are shown. (I) CellChat analysis of ligand-receptor interaction pairs. Treg cells are set as the ligand source and other leukocytes as the recipients. Communication probability from the control and ΔIL33 Col1α2 (conditional knockout [cKO]) groups are shown. (J) Violin plots of Mif and Tgfb1 expression in Treg cell cluster from control and ΔIL33 Col1α2 groups. (K) Flow cytometry plots of MIF and TGF-β1 expression in FOXP3 + Treg cells from day 2 wounds of control or ΔIL33 Col1α2 mice. (L) Mean fluorescent intensity (MFI) for MIF or TGF-β1 expression in FOXP3 + Treg cells in day 2 wounds. Data represent mean ± SEM; n = 3–5 mice per group. Student’s t test, * p < 0.05.
    Foxp3 Rabbit Anti Human Antibody, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/anti+foxp3/10__1097_slash_cm9__0000000000003918-63-45-51
    Average 86 stars, based on 1 article reviews
    foxp3 rabbit anti human antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rabbit anti human foxp3 monoclonal antibodies
    Molecular characterization of distinct TME cell population and expression signature in gastric cancer. (A) Box plot showing differences in genes expression between normal tissue and gastric tumor tissue and dot plot showing pair comparison between normal tissue and gastric tumor tissue of TNFRSF4 , TNFSF4 , IL-2 , IL2RA , IL2RB, and IL2RG expression. (B) Survival analysis with Kaplan-Meier method for STAD patients grouped by the expression level of TNFRSF4 and TNFSF4. (C) UMAP representation of tissue; normal tissue (red), primary tumor (light blue), from GSE163558 . (D) UMAP plot of single-cell transcriptomic profiles grouped into the major cell types clusters from GSE163558 . (E) Expression of marker genes for identification of T cells and NK cells. (F) Expression of TNFRSF4 , TNFSF4 , and <t>FOXP3</t> marker genes. ns, not significant; **, P<0.01; ***, P<0.001. CI, confidence interval; HR, hazard ratio; NK, natural killer; STAD, stomach adenocarcinoma; TME, tumor microenvironment; UMAP, Uniform Manifold Approximation and Projection.
    Rabbit Anti Human Foxp3 Monoclonal Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Rabbit+mAb/pmc12776187-91-46-51
    Average 93 stars, based on 1 article reviews
    rabbit anti human foxp3 monoclonal antibodies - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems rabbit anti mouse foxp3 polyclonal antibody
    Molecular characterization of distinct TME cell population and expression signature in gastric cancer. (A) Box plot showing differences in genes expression between normal tissue and gastric tumor tissue and dot plot showing pair comparison between normal tissue and gastric tumor tissue of TNFRSF4 , TNFSF4 , IL-2 , IL2RA , IL2RB, and IL2RG expression. (B) Survival analysis with Kaplan-Meier method for STAD patients grouped by the expression level of TNFRSF4 and TNFSF4. (C) UMAP representation of tissue; normal tissue (red), primary tumor (light blue), from GSE163558 . (D) UMAP plot of single-cell transcriptomic profiles grouped into the major cell types clusters from GSE163558 . (E) Expression of marker genes for identification of T cells and NK cells. (F) Expression of TNFRSF4 , TNFSF4 , and <t>FOXP3</t> marker genes. ns, not significant; **, P<0.01; ***, P<0.001. CI, confidence interval; HR, hazard ratio; NK, natural killer; STAD, stomach adenocarcinoma; TME, tumor microenvironment; UMAP, Uniform Manifold Approximation and Projection.
    Rabbit Anti Mouse Foxp3 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/Human%2FMouse+FoxP3+Antibody/pm40643216-83-0-5
    Average 93 stars, based on 1 article reviews
    rabbit anti mouse foxp3 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti human foxp3
    Immunofluorescence staining verifies distinct immune archetypes (A) Representative fields selected from tissue section immunofluorescence (IF) staining of patients classified by archetypes (columns), highlighting three major cell types (rows). CTSK marks the OC population, CD4 and <t>FOXP3</t> double-positive signals indicate CD4 Treg populations, and CD8A and TIM3 double-positive signals represent CD8 Tex populations. (B) Cell counting from IF staining of tissue sections from 21 patients, grouped by archetypes: Mφ-OC ( N = 6 patients), Treg-Tex ( N = 8 patients), and Mono ( N = 7 patients). Three major cell types were analyzed: OC cells were manually counted from entire tissue sections. Treg and Tex populations were quantified from selected fields (regions of interest based on CD4 or CD8A positivity, shown in ). Left: Proportion of OC cells out of total cells; Middle: Proportion of CD4 Tregs out of total CD4 T cells; Right: Proportion of CD8 Tex cells out of total CD8 T cells. (Significance test: One-way ANOVA, ∗ p < 0.05; ∗∗ p < 0.01).
    Rabbit Anti Human Foxp3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Rabbit+mAb/pmc12278635-18-0-5
    Average 96 stars, based on 1 article reviews
    rabbit anti human foxp3 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti human foxp3 d2w8e
    Chemo-/radiotherapy and ICI immunotherapy affect pHGG immune microenvironment (A) Proportions (left and middle) of myeloid cell subpopulation, represented by each individual program, and quantification of observed changes (right) by treatment status in this pHGG cohort. (B) Proportions (left and middle) of CD8 + T cell subpopulation, represented by each individual program, and quantification of changes (right) by treatment status in this pHGG cohort. Fewer samples due to absent CD8 + T cells in the respective samples. (C) Proportions of CD4 + T cell subpopulations, represented by each individual program, by ICI status in this pHGG cohort. Asterisk denotes significant observed change in proportion ( p ≤ 0.05). Statistical significance assessed using the propeller function from the R package speckle. Fewer ITN samples due to absent CD4 + T cells in the respective samples. (D) Multiplex IHC staining for <t>FOXP3</t> (Treg marker) in samples from ICI-treated and ITN patient ( n = 3 each, n images = 12). Scale bar, 300 μm. (E) Quantification of (D): change in observed Treg proportion, normalized to DAPI-positive cells. Student’s t test used to calculate significance. Data are represented as mean ± SEM. (F) Heatmap depicting centered expression values (TPM, transcripts per million) of indicated mRNAs in CD4 + and CD8 + T cells by immunotherapy status. (G) Proportions of myeloid cell subpopulations, represented by each individual program, by immunotherapy status in this pHGG cohort. Colors represent samples from different recurrences in the same patient. (H) Dotplot depicting relative marker gene expression of indicated T cell programs for CD8 + T cells from glioma (our pHGG cohort, adult glioma, and melanoma ). Size of points denote the percentage of cells that the respective gene is expressed in. (I) Proportion of CD8 + T cell subpopulations in same datasets as (H). (J) Proportion of detected CD4 + Treg cells in the indicated cohorts, before and after ICI treatment. Data are represented as mean ± SEM. Significance assessed via Student’s t test.
    Anti Human Foxp3 D2w8e, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+foxp3/FoxP3+Rabbit+mAb/pmc12147851-8-0-4
    Average 96 stars, based on 1 article reviews
    anti human foxp3 d2w8e - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) Representative flow cytometry plot and gating strategy for determining ST2 + cell identity in day 2 oral wounds. (B) EPCAM + (epithelial), PDGFRA + (fibroblast), CD31 + (endothelial), and CD45 + (leukocyte) cells that express ST2, normalized by total ST2 + cell count per time point. (C) scRNA-seq analysis and UMAP plot of CD45 + sorted cells from day 2 wounds of control Il33 f/f mice (Ctrl) and experimental ΔIL33 Col1α2 mice. 8–10 wounds from 4–5 mice were pooled per condition. (D) Left: UMAP of subset clusters that express Il1rl1 + (encoding ST2). Right: feature plot of Il1rl1 expression in three clusters. (E) Dot plot for genes that are enriched in Treg cells, including Foxp3 . (F) Il1rl1 + cell numbers in each cluster normalized by total number of Il1rl1 + cells. Treg, regulatory T cell; MC, mast cell; ILC2, type 2 innate lymphoid cell. (G) Pseudobulk analysis of DEGs, comparing Treg cells from control versus ΔIL33 Col1α2 groups. (H) GO analysis for the upregulated gene list in control Treg cells. Biological process terms associated with immune responses are shown. (I) CellChat analysis of ligand-receptor interaction pairs. Treg cells are set as the ligand source and other leukocytes as the recipients. Communication probability from the control and ΔIL33 Col1α2 (conditional knockout [cKO]) groups are shown. (J) Violin plots of Mif and Tgfb1 expression in Treg cell cluster from control and ΔIL33 Col1α2 groups. (K) Flow cytometry plots of MIF and TGF-β1 expression in FOXP3 + Treg cells from day 2 wounds of control or ΔIL33 Col1α2 mice. (L) Mean fluorescent intensity (MFI) for MIF or TGF-β1 expression in FOXP3 + Treg cells in day 2 wounds. Data represent mean ± SEM; n = 3–5 mice per group. Student’s t test, * p < 0.05.

    Journal: Cell reports

    Article Title: Fibroblast-derived alarmin promotes oral wound healing by activating regulatory T cells that relay pro-angiogenic and anti-inflammatory responses

    doi: 10.1016/j.celrep.2025.116829

    Figure Lengend Snippet: (A) Representative flow cytometry plot and gating strategy for determining ST2 + cell identity in day 2 oral wounds. (B) EPCAM + (epithelial), PDGFRA + (fibroblast), CD31 + (endothelial), and CD45 + (leukocyte) cells that express ST2, normalized by total ST2 + cell count per time point. (C) scRNA-seq analysis and UMAP plot of CD45 + sorted cells from day 2 wounds of control Il33 f/f mice (Ctrl) and experimental ΔIL33 Col1α2 mice. 8–10 wounds from 4–5 mice were pooled per condition. (D) Left: UMAP of subset clusters that express Il1rl1 + (encoding ST2). Right: feature plot of Il1rl1 expression in three clusters. (E) Dot plot for genes that are enriched in Treg cells, including Foxp3 . (F) Il1rl1 + cell numbers in each cluster normalized by total number of Il1rl1 + cells. Treg, regulatory T cell; MC, mast cell; ILC2, type 2 innate lymphoid cell. (G) Pseudobulk analysis of DEGs, comparing Treg cells from control versus ΔIL33 Col1α2 groups. (H) GO analysis for the upregulated gene list in control Treg cells. Biological process terms associated with immune responses are shown. (I) CellChat analysis of ligand-receptor interaction pairs. Treg cells are set as the ligand source and other leukocytes as the recipients. Communication probability from the control and ΔIL33 Col1α2 (conditional knockout [cKO]) groups are shown. (J) Violin plots of Mif and Tgfb1 expression in Treg cell cluster from control and ΔIL33 Col1α2 groups. (K) Flow cytometry plots of MIF and TGF-β1 expression in FOXP3 + Treg cells from day 2 wounds of control or ΔIL33 Col1α2 mice. (L) Mean fluorescent intensity (MFI) for MIF or TGF-β1 expression in FOXP3 + Treg cells in day 2 wounds. Data represent mean ± SEM; n = 3–5 mice per group. Student’s t test, * p < 0.05.

    Article Snippet: Rabbit monoclonal anti-human FOXP3 (clone D2W8E) , Cell Signaling Technology , Cat. #: 98377T; RRID: AB_2747370.

    Techniques: Flow Cytometry, Cell Characterization, Control, Expressing, Knock-Out

    (A) H&E-stained images (left) and epithelial gap quantification (right) of day 2 oral wounds from Foxp3-DTR mice that received saline or diphtheria toxin (DT). Scale bar, 500 μm. (B) Left: COL3A1 staining images from day 4 oral wounds. Right: COL3A1 + area in control and Treg cell ablation mice. Scale bar, 500 μm. (C) LY6C + VEGFA + monocyte numbers normalized by stromal area in day 2 or 4 oral wounds. (D) F4/80 + CD206 + macrophage numbers normalized by stromal area in day 2 or 4 oral wounds. (E) MIF and TGF-β1 levels by ELISA from day 2 wound lysates, normalized by tissue weight. (F) CD31 + blood vessel numbers normalized by stromal area in day 2 or 4 oral wounds. (G and H) Flow cytometry plots (G) and quantification (H) of CD74 + LY6C + monocytes and F4/80 + CD206 + macrophages in day 4 oral wounds of Treg cell ablation mice that received vehicle (+saline) or recombinant MIF and TGF-β1 (+rMIF/TGF-β1, 5 ng/1 ng per wound). (I and J) CD31 + blood vessels (I) and COL3A1 + stromal area (J) in the wounds of Treg cell ablation mice that received saline or rMIF/TGF-β1. Data represent mean ± SEM. n = 5–10 mice each. Student’s t test; * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Cell reports

    Article Title: Fibroblast-derived alarmin promotes oral wound healing by activating regulatory T cells that relay pro-angiogenic and anti-inflammatory responses

    doi: 10.1016/j.celrep.2025.116829

    Figure Lengend Snippet: (A) H&E-stained images (left) and epithelial gap quantification (right) of day 2 oral wounds from Foxp3-DTR mice that received saline or diphtheria toxin (DT). Scale bar, 500 μm. (B) Left: COL3A1 staining images from day 4 oral wounds. Right: COL3A1 + area in control and Treg cell ablation mice. Scale bar, 500 μm. (C) LY6C + VEGFA + monocyte numbers normalized by stromal area in day 2 or 4 oral wounds. (D) F4/80 + CD206 + macrophage numbers normalized by stromal area in day 2 or 4 oral wounds. (E) MIF and TGF-β1 levels by ELISA from day 2 wound lysates, normalized by tissue weight. (F) CD31 + blood vessel numbers normalized by stromal area in day 2 or 4 oral wounds. (G and H) Flow cytometry plots (G) and quantification (H) of CD74 + LY6C + monocytes and F4/80 + CD206 + macrophages in day 4 oral wounds of Treg cell ablation mice that received vehicle (+saline) or recombinant MIF and TGF-β1 (+rMIF/TGF-β1, 5 ng/1 ng per wound). (I and J) CD31 + blood vessels (I) and COL3A1 + stromal area (J) in the wounds of Treg cell ablation mice that received saline or rMIF/TGF-β1. Data represent mean ± SEM. n = 5–10 mice each. Student’s t test; * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: Rabbit monoclonal anti-human FOXP3 (clone D2W8E) , Cell Signaling Technology , Cat. #: 98377T; RRID: AB_2747370.

    Techniques: Staining, Saline, Control, Enzyme-linked Immunosorbent Assay, Flow Cytometry, Recombinant

    (A) H&E staining and immunofluorescence images of normal human gingiva and skin. Dashed lines demarcate the boundaries of reticular connective tissue. Scale bar, 500 μm. Inset: respective areas (i–iv) in gingiva and skin, showing immunopositive signals for IL-33, PI16, and CD31. Scale bar, 50 μm. (B) PI16 + IL33 + cell counts per area in the deeper connective tissue of skin dermis and oral lamina propria. (C) Illustrative diagram of inadvertent implant abutment removal and tissue resection for histological assessment. (D) H&E staining and immunofluorescence images of human gingiva that “healed” for 4 days after abutment removal; n = 3 individual patients (56M, 56F, and 54M). Scale bar, 500 μm. Inset: deeper lamina propria showing immunopositive signals for KI67, KRT14, and CD45 antigen. Scale bar, 100 μm. (E) RNAscope in situ hybridization images with specific probes against FOXP3 , MIF , and TGFB1 . The upper and lower aspect of healing gingival connective tissue is shown. Scale bar, 100 μm. Inset: representative Treg cells in the upper (i) and lower (ii) lamina propria (LP). Scale bar, 5 μm. (F) FOXP3 + MIF + (left) and FOXP3 + TGFB1 + Treg cell count per area (right) from the upper versus lower lamina propria in healing gingiva. (G) MIF and TGFB1 puncta in FOXP3 + cells from the lower lamina propria. Data represent mean ± SEM; n = 5–7 individuals per group (B), 3 specimens (F), and 30 fields of view (FOV) (G) from three patients. Student’s t test, * p < 0.05, ** p < 0.01.

    Journal: Cell reports

    Article Title: Fibroblast-derived alarmin promotes oral wound healing by activating regulatory T cells that relay pro-angiogenic and anti-inflammatory responses

    doi: 10.1016/j.celrep.2025.116829

    Figure Lengend Snippet: (A) H&E staining and immunofluorescence images of normal human gingiva and skin. Dashed lines demarcate the boundaries of reticular connective tissue. Scale bar, 500 μm. Inset: respective areas (i–iv) in gingiva and skin, showing immunopositive signals for IL-33, PI16, and CD31. Scale bar, 50 μm. (B) PI16 + IL33 + cell counts per area in the deeper connective tissue of skin dermis and oral lamina propria. (C) Illustrative diagram of inadvertent implant abutment removal and tissue resection for histological assessment. (D) H&E staining and immunofluorescence images of human gingiva that “healed” for 4 days after abutment removal; n = 3 individual patients (56M, 56F, and 54M). Scale bar, 500 μm. Inset: deeper lamina propria showing immunopositive signals for KI67, KRT14, and CD45 antigen. Scale bar, 100 μm. (E) RNAscope in situ hybridization images with specific probes against FOXP3 , MIF , and TGFB1 . The upper and lower aspect of healing gingival connective tissue is shown. Scale bar, 100 μm. Inset: representative Treg cells in the upper (i) and lower (ii) lamina propria (LP). Scale bar, 5 μm. (F) FOXP3 + MIF + (left) and FOXP3 + TGFB1 + Treg cell count per area (right) from the upper versus lower lamina propria in healing gingiva. (G) MIF and TGFB1 puncta in FOXP3 + cells from the lower lamina propria. Data represent mean ± SEM; n = 5–7 individuals per group (B), 3 specimens (F), and 30 fields of view (FOV) (G) from three patients. Student’s t test, * p < 0.05, ** p < 0.01.

    Article Snippet: Rabbit monoclonal anti-human FOXP3 (clone D2W8E) , Cell Signaling Technology , Cat. #: 98377T; RRID: AB_2747370.

    Techniques: Staining, Immunofluorescence, RNAscope, In Situ Hybridization, Cell Characterization

    Molecular characterization of distinct TME cell population and expression signature in gastric cancer. (A) Box plot showing differences in genes expression between normal tissue and gastric tumor tissue and dot plot showing pair comparison between normal tissue and gastric tumor tissue of TNFRSF4 , TNFSF4 , IL-2 , IL2RA , IL2RB, and IL2RG expression. (B) Survival analysis with Kaplan-Meier method for STAD patients grouped by the expression level of TNFRSF4 and TNFSF4. (C) UMAP representation of tissue; normal tissue (red), primary tumor (light blue), from GSE163558 . (D) UMAP plot of single-cell transcriptomic profiles grouped into the major cell types clusters from GSE163558 . (E) Expression of marker genes for identification of T cells and NK cells. (F) Expression of TNFRSF4 , TNFSF4 , and FOXP3 marker genes. ns, not significant; **, P<0.01; ***, P<0.001. CI, confidence interval; HR, hazard ratio; NK, natural killer; STAD, stomach adenocarcinoma; TME, tumor microenvironment; UMAP, Uniform Manifold Approximation and Projection.

    Journal: Translational Cancer Research

    Article Title: OX40L and IL-2 combination strategy for gastric cancer immunotherapy

    doi: 10.21037/tcr-2025-707

    Figure Lengend Snippet: Molecular characterization of distinct TME cell population and expression signature in gastric cancer. (A) Box plot showing differences in genes expression between normal tissue and gastric tumor tissue and dot plot showing pair comparison between normal tissue and gastric tumor tissue of TNFRSF4 , TNFSF4 , IL-2 , IL2RA , IL2RB, and IL2RG expression. (B) Survival analysis with Kaplan-Meier method for STAD patients grouped by the expression level of TNFRSF4 and TNFSF4. (C) UMAP representation of tissue; normal tissue (red), primary tumor (light blue), from GSE163558 . (D) UMAP plot of single-cell transcriptomic profiles grouped into the major cell types clusters from GSE163558 . (E) Expression of marker genes for identification of T cells and NK cells. (F) Expression of TNFRSF4 , TNFSF4 , and FOXP3 marker genes. ns, not significant; **, P<0.01; ***, P<0.001. CI, confidence interval; HR, hazard ratio; NK, natural killer; STAD, stomach adenocarcinoma; TME, tumor microenvironment; UMAP, Uniform Manifold Approximation and Projection.

    Article Snippet: Immunohistochemistry (IHC) analyses were performed using specific primary rabbit anti-human CD3 monoclonal antibody (Proteintech Group, Wuhan, China), mouse anti-human OX40 and rabbit anti-human OX40L monoclonal antibodies (CST, Danvers, MA, USA), and rabbit anti-human CD4 (Proteintech Group, Wuhan, China), mouse anti-human CD8 (Proteintech Group, Wuhan, China) antibody, rabbit anti-human FOXP3 monoclonal antibodies (CST, Danvers, MA, USA).

    Techniques: Expressing, Comparison, Marker

    Immunohistochemical and flow cytometric analysis of gastric cancer tissue. (A) H&E histochemical staining of tumor-free area (left), tumor margin (middle), and gastric tumor site (right). (B) Representative IHC images for CD3 + , CD4 + , CD8 + , FOXP3, OX40, and OX40L in tumor-free area (left column), tumor margin (middle column), and gastric tumor site (right column) sections. (C) Immunofluorescence staining for the co-expression of CD3 + and OX40 in gastric cancer with anti-CD3 and anti-OX40 antibodies and DAPI for nuclear staining. (D) Flow cytometry analysis of OX40 expression in CD3 cells obtained from PBMC of gastric cancer patients (upper panel) and OX40 expression on CD3 on TILs in gastric cancer patients (low panel). Statistical analysis of all data were performed using one-way ANOVA. Data are shown as mean ± standard deviation. ns, nonsignificant; *, P<0.05; ***, P<0.001. ANOVA, analysis of variance; DAPI, 4',6-diamidino-2-phenylindole; H&E, hematoxylin & eosin; IHC, immunohistochemistry; OX40L, OX40 ligand; PBMC, peripheral blood mononuclear cells; TILs, tumor-infiltrating lymphocytes.

    Journal: Translational Cancer Research

    Article Title: OX40L and IL-2 combination strategy for gastric cancer immunotherapy

    doi: 10.21037/tcr-2025-707

    Figure Lengend Snippet: Immunohistochemical and flow cytometric analysis of gastric cancer tissue. (A) H&E histochemical staining of tumor-free area (left), tumor margin (middle), and gastric tumor site (right). (B) Representative IHC images for CD3 + , CD4 + , CD8 + , FOXP3, OX40, and OX40L in tumor-free area (left column), tumor margin (middle column), and gastric tumor site (right column) sections. (C) Immunofluorescence staining for the co-expression of CD3 + and OX40 in gastric cancer with anti-CD3 and anti-OX40 antibodies and DAPI for nuclear staining. (D) Flow cytometry analysis of OX40 expression in CD3 cells obtained from PBMC of gastric cancer patients (upper panel) and OX40 expression on CD3 on TILs in gastric cancer patients (low panel). Statistical analysis of all data were performed using one-way ANOVA. Data are shown as mean ± standard deviation. ns, nonsignificant; *, P<0.05; ***, P<0.001. ANOVA, analysis of variance; DAPI, 4',6-diamidino-2-phenylindole; H&E, hematoxylin & eosin; IHC, immunohistochemistry; OX40L, OX40 ligand; PBMC, peripheral blood mononuclear cells; TILs, tumor-infiltrating lymphocytes.

    Article Snippet: Immunohistochemistry (IHC) analyses were performed using specific primary rabbit anti-human CD3 monoclonal antibody (Proteintech Group, Wuhan, China), mouse anti-human OX40 and rabbit anti-human OX40L monoclonal antibodies (CST, Danvers, MA, USA), and rabbit anti-human CD4 (Proteintech Group, Wuhan, China), mouse anti-human CD8 (Proteintech Group, Wuhan, China) antibody, rabbit anti-human FOXP3 monoclonal antibodies (CST, Danvers, MA, USA).

    Techniques: Immunohistochemical staining, Staining, Immunofluorescence, Expressing, Flow Cytometry, Standard Deviation, Immunohistochemistry

    Immunofluorescence staining verifies distinct immune archetypes (A) Representative fields selected from tissue section immunofluorescence (IF) staining of patients classified by archetypes (columns), highlighting three major cell types (rows). CTSK marks the OC population, CD4 and FOXP3 double-positive signals indicate CD4 Treg populations, and CD8A and TIM3 double-positive signals represent CD8 Tex populations. (B) Cell counting from IF staining of tissue sections from 21 patients, grouped by archetypes: Mφ-OC ( N = 6 patients), Treg-Tex ( N = 8 patients), and Mono ( N = 7 patients). Three major cell types were analyzed: OC cells were manually counted from entire tissue sections. Treg and Tex populations were quantified from selected fields (regions of interest based on CD4 or CD8A positivity, shown in ). Left: Proportion of OC cells out of total cells; Middle: Proportion of CD4 Tregs out of total CD4 T cells; Right: Proportion of CD8 Tex cells out of total CD8 T cells. (Significance test: One-way ANOVA, ∗ p < 0.05; ∗∗ p < 0.01).

    Journal: Cell Genomics

    Article Title: Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization

    doi: 10.1016/j.xgen.2025.100888

    Figure Lengend Snippet: Immunofluorescence staining verifies distinct immune archetypes (A) Representative fields selected from tissue section immunofluorescence (IF) staining of patients classified by archetypes (columns), highlighting three major cell types (rows). CTSK marks the OC population, CD4 and FOXP3 double-positive signals indicate CD4 Treg populations, and CD8A and TIM3 double-positive signals represent CD8 Tex populations. (B) Cell counting from IF staining of tissue sections from 21 patients, grouped by archetypes: Mφ-OC ( N = 6 patients), Treg-Tex ( N = 8 patients), and Mono ( N = 7 patients). Three major cell types were analyzed: OC cells were manually counted from entire tissue sections. Treg and Tex populations were quantified from selected fields (regions of interest based on CD4 or CD8A positivity, shown in ). Left: Proportion of OC cells out of total cells; Middle: Proportion of CD4 Tregs out of total CD4 T cells; Right: Proportion of CD8 Tex cells out of total CD8 T cells. (Significance test: One-way ANOVA, ∗ p < 0.05; ∗∗ p < 0.01).

    Article Snippet: Rabbit anti-Human FoxP3, 1:100 , Cell Signaling Technology , Cat# 98377; RRID: AB_2747370.

    Techniques: Immunofluorescence, Staining, Cell Counting

    Chemo-/radiotherapy and ICI immunotherapy affect pHGG immune microenvironment (A) Proportions (left and middle) of myeloid cell subpopulation, represented by each individual program, and quantification of observed changes (right) by treatment status in this pHGG cohort. (B) Proportions (left and middle) of CD8 + T cell subpopulation, represented by each individual program, and quantification of changes (right) by treatment status in this pHGG cohort. Fewer samples due to absent CD8 + T cells in the respective samples. (C) Proportions of CD4 + T cell subpopulations, represented by each individual program, by ICI status in this pHGG cohort. Asterisk denotes significant observed change in proportion ( p ≤ 0.05). Statistical significance assessed using the propeller function from the R package speckle. Fewer ITN samples due to absent CD4 + T cells in the respective samples. (D) Multiplex IHC staining for FOXP3 (Treg marker) in samples from ICI-treated and ITN patient ( n = 3 each, n images = 12). Scale bar, 300 μm. (E) Quantification of (D): change in observed Treg proportion, normalized to DAPI-positive cells. Student’s t test used to calculate significance. Data are represented as mean ± SEM. (F) Heatmap depicting centered expression values (TPM, transcripts per million) of indicated mRNAs in CD4 + and CD8 + T cells by immunotherapy status. (G) Proportions of myeloid cell subpopulations, represented by each individual program, by immunotherapy status in this pHGG cohort. Colors represent samples from different recurrences in the same patient. (H) Dotplot depicting relative marker gene expression of indicated T cell programs for CD8 + T cells from glioma (our pHGG cohort, adult glioma, and melanoma ). Size of points denote the percentage of cells that the respective gene is expressed in. (I) Proportion of CD8 + T cell subpopulations in same datasets as (H). (J) Proportion of detected CD4 + Treg cells in the indicated cohorts, before and after ICI treatment. Data are represented as mean ± SEM. Significance assessed via Student’s t test.

    Journal: Cell Reports Medicine

    Article Title: Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure

    doi: 10.1016/j.xcrm.2025.102095

    Figure Lengend Snippet: Chemo-/radiotherapy and ICI immunotherapy affect pHGG immune microenvironment (A) Proportions (left and middle) of myeloid cell subpopulation, represented by each individual program, and quantification of observed changes (right) by treatment status in this pHGG cohort. (B) Proportions (left and middle) of CD8 + T cell subpopulation, represented by each individual program, and quantification of changes (right) by treatment status in this pHGG cohort. Fewer samples due to absent CD8 + T cells in the respective samples. (C) Proportions of CD4 + T cell subpopulations, represented by each individual program, by ICI status in this pHGG cohort. Asterisk denotes significant observed change in proportion ( p ≤ 0.05). Statistical significance assessed using the propeller function from the R package speckle. Fewer ITN samples due to absent CD4 + T cells in the respective samples. (D) Multiplex IHC staining for FOXP3 (Treg marker) in samples from ICI-treated and ITN patient ( n = 3 each, n images = 12). Scale bar, 300 μm. (E) Quantification of (D): change in observed Treg proportion, normalized to DAPI-positive cells. Student’s t test used to calculate significance. Data are represented as mean ± SEM. (F) Heatmap depicting centered expression values (TPM, transcripts per million) of indicated mRNAs in CD4 + and CD8 + T cells by immunotherapy status. (G) Proportions of myeloid cell subpopulations, represented by each individual program, by immunotherapy status in this pHGG cohort. Colors represent samples from different recurrences in the same patient. (H) Dotplot depicting relative marker gene expression of indicated T cell programs for CD8 + T cells from glioma (our pHGG cohort, adult glioma, and melanoma ). Size of points denote the percentage of cells that the respective gene is expressed in. (I) Proportion of CD8 + T cell subpopulations in same datasets as (H). (J) Proportion of detected CD4 + Treg cells in the indicated cohorts, before and after ICI treatment. Data are represented as mean ± SEM. Significance assessed via Student’s t test.

    Article Snippet: Anti-human FoxP3 (D2W8E) , Cell Signaling , Cat# 98377; RRID: AB_2747370.

    Techniques: Multiplex Assay, Immunohistochemistry, Marker, Expressing, Gene Expression